FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER
leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose
LOE Approaching
Baxter
INJECTION · INJECTABLE
1997
NDA
30/100
CLINORIL
sulindac
LOE Approaching
Merck & Co.
ORAL · TABLET
Rheumatoid arthritis
1978
NDA
30/100
CLOBEX
clobetasol propionate
LOE Approaching
Galderma
TOPICAL · LOTION
psoriasis
2003
NDA
30/100
CLOBEX
clobetasol propionate
LOE Approaching
Galderma
TOPICAL · SHAMPOO
moderate to severe scalp psoriasis in subjects 18 years of ageolder+2
2004
NDA
30/100
CLOBEX
clobetasol propionate
LOE Approaching
Galderma
TOPICAL · SPRAY
moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of ageolder+1
2005
NDA
30/100
CLODERM
clocortolone pivalate
LOE Approaching
Enterprise Therapeutics
TOPICAL · CREAM
1977
NDA
30/100
CLOLAR
clofarabine
LOE Approaching
Sanofi
INTRAVENOUS · SOLUTION
refractory acute lymphoblastic leukemia after at least two prior regimensleukemia
2004
NDA
30/100
CLOMID
clomiphene citrate
LOE Approaching
Sanofi
ORAL · TABLET
ovulatory dysfunction in women desiring pregnancy
1967
NDA
30/100
CLONIDINE
clonidine
LOE Approaching
ORAL · SUSPENSION, EXTENDED RELEASE
the treatment of hypertensionhypertension
2009
NDA
30/100
CLOZARIL
clozapine
LOE Approaching
Charter Medical
ORAL · TABLET
severely ill patients with schizophreniaschizophrenia
1989
NDA
30/100
COARTEM
artemether and lumefantrine
LOE Approaching
Novartis
ORAL · TABLET
acuteuncomplicated malaria infections due to Plasmodium falciparum (P
2009
NDA
30/100
CODEINE SULFATE
codeine sulfate
LOE Approaching
Hikma
ORAL · TABLET
mild to moderate painwhere treatment with an opioid is appropriate+1
2009
NDA
30/100
CODEPREX
chlorpheniramine polistirex; codeine polistirex
LOE Approaching
ORAL · SUSPENSION, EXTENDED RELEASE
2004
NDA
30/100
COGENTIN
benztropine mesylate
LOE Approaching
Merck & Co.
ORAL · TABLET
of extrapyramidal disorders (except tardive dyskinesia – see ) due to neuroleptic drugs (e
1954
NDA
30/100
COGENTIN
benztropine mesylate
LOE Approaching
INJECTION · INJECTABLE
of extrapyramidal disorders (except tardive dyskinesia – see ) due to neuroleptic drugs (e
1959
NDA
30/100
COGNEX
tacrine hydrochloride
LOE Approaching
Shionogi
ORAL · CAPSULE
1993
NDA
30/100
COLBENEMID
colchicine; probenecid
LOE Approaching
Merck & Co.
ORAL · TABLET
gout flaresacute gout flares+2
1961
NDA
30/100
COLCRYS
colchicine
LOE Approaching
Molecular Devices
ORAL · TABLET
gout flaresacute gout flares+2
2009
NDA
30/100
← PreviousPage 34 of 188Next →